GS-9620 alleviates psoriasis-like inflammation by regulating autophagy in keratinocytes

Yansi Lyu , Wei Zhou , Pei Zhang , Chen Lin , Xin Wen , Zigang Zhao , Guoqiang Zhang , Qian Zhang , Si Chen

Animal Models and Experimental Medicine ›› 2026, Vol. 9 ›› Issue (7) : 1364 -1372.

PDF (3848KB)
Animal Models and Experimental Medicine ›› 2026, Vol. 9 ›› Issue (7) :1364 -1372. DOI: 10.1002/ame2.70222
ORIGINAL ARTICLE
GS-9620 alleviates psoriasis-like inflammation by regulating autophagy in keratinocytes
Author information +
History +
PDF (3848KB)

Abstract

Background: Psoriasis is an immune-driven dermatosis marked by keratinocyte hyperproliferation. GS-9620, a TLR7 agonist, previously mitigated EV71-triggered inflammation in mice; here we probe its anti-psoriatic potential and mechanisms.

Methods: IMQ-induced psoriasis-like mice were treated with GS-9620 or MTX; severity was tracked by PASI and histology. Skin/spleen cytokines (IL-1β, IL-6, IL-18, HMGB1, TNF-α) were quantified via ELISA; immune subsets were quantified by flow cytometry. Autophagy proteins (ATG5/12/16 L1) and NLRP3 were assessed by IHC/Western blot. In vitro, M5-stimulated primary keratinocytes were treated with GS-9620 ± autophagy modulators, followed by cytokine and protein analyses.

Results: GS-9620 markedly reduced erythema, scaling and epidermal thickness, lowered skin and systemic cytokines, and decreased splenic CD3+/CD4+IL-17A+ cells. It restored ATG5/12/16 L1 expression while suppressing NLRP3 both in lesions and in M5-stimulated keratinocytes, leading to diminished IL-1β, IL-6, IL-18, HMGB1 and TNF-α release.

Conclusions: GS-9620 alleviates psoriasis by enhancing autophagy and dampening NLRP3-mediated inflammation, offering a promising therapeutic avenue.

Keywords

anti-psoriasis drugs / autophagy / GS-9620 / NLRP3 / PASI / psoriasis

Cite this article

Download citation ▾
Yansi Lyu, Wei Zhou, Pei Zhang, Chen Lin, Xin Wen, Zigang Zhao, Guoqiang Zhang, Qian Zhang, Si Chen. GS-9620 alleviates psoriasis-like inflammation by regulating autophagy in keratinocytes. Animal Models and Experimental Medicine, 2026, 9 (7) : 1364-1372 DOI:10.1002/ame2.70222

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Yan K, Zhang Y, Han L, et al. Safety and efficacy of methotrexate for Chinese adults with psoriasis with and without psoriatic arthritis. JAMA Dermatol. 2019; 155(3): 327-334.

[2]

Rendon A, Schäkel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019; 20(6): E1475.

[3]

Gao J, Chen F, Fang H, Mi J, Qi Q, Yang M. Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice. Biol Res. 2020; 53(1): 48.

[4]

Albanesi C, De Pità O, Girolomoni G. Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes. Clin Dermatol. 2007; 25(6): 581-588.

[5]

Hawkes JE, Chan TC, Krueger JG. Psoriasis pathogenesis and the development of novel targeted immune therapies. J Allergy Clin Immunol. 2017; 140(3): 645-653.

[6]

Netea-Maier RT, Plantinga TS, van de Veerdonk FL, Smit JW, Netea MG. Modulation of inflammation by autophagy: consequences for human disease. Autophagy. 2016; 12(2): 245-260.

[7]

Deretic V, Levine B. Autophagy balances inflammation in innate immunity. Autophagy. 2018; 14(2): 243-251.

[8]

Lin T-Y, Chan H-H, Chen S-H, et al. BIRC5/Survivin is a novel ATG12-ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells. Autophagy. 2020; 16(7): 1296-1313.

[9]

Tack CJ, Stienstra R, Joosten LAB, Netea MG. Inflammation links excess fat to insulin resistance: the role of the interleukin-1 family. Immunol Rev. 2012; 249(1): 239-252.

[10]

Zou Y-J, Xu J-J, Wang X, Zhu Y-H, Wu Q, Wang J-F. Lactobacillus johnsonii L531 ameliorates Escherichia coli-induced cell damage via inhibiting NLRP3 inflammasome activity and promoting ATG5/ATG16L1-mediated autophagy in porcine mammary epithelial cells. Vet Sci. 2020; 7(3): 112.

[11]

Niu C, Li L, Daffis S, et al. Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism. J Hepatol. 2018; 68(5): 922-931.

[12]

Ram RR, Duatschek P, Margot N, et al. Activation of HIV-specific CD8+ T-cells from HIV+ donors by vesatolimod. Antivir Ther. 2020; 25(3): 163-169.

[13]

Zhang Q, Zhao B, Chen X, et al. GS-9620 inhibits enterovirus 71 replication mainly through the NF-κB and PI3K-AKT signaling pathways. Antivir Res. 2018; 153: 39-48.

[14]

Langley RG, Ellis CN. Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system Physician's global assessment. J Am Acad Dermatol. 2004; 51(4): 563-569.

[15]

Aasen T, Izpisúa Belmonte JC. Isolation and cultivation of human keratinocytes from skin or plucked hair for the generation of induced pluripotent stem cells. Nat Protoc. 2010; 5(2): 371-382.

[16]

Na Takuathung M, Wongnoppavich A, Panthong A, et al. Antipsoriatic effects of Wannachawee recipe on imiquimod-induced psoriasis-like dermatitis in BALB/c mice. Evid-Based Complement Altern Med ECAM. 2018; 2018:7931031.

[17]

Levine B, Kroemer G. Biological functions of autophagy genes: a disease perspective. Cell. 2019; 176(1–2): 11-42.

[18]

Teng X, Hu Z, Wei X, et al. IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production. J Immunol Baltim Md. 2014; 192(4): 1815-1823.

[19]

Guilloteau K, Paris I, Pedretti N, et al. Skin inflammation induced by the synergistic action of IL-17A, IL-22, Oncostatin M, IL-1α, and TNF-α recapitulates some features of psoriasis. J Immunol Baltim Md. 2010; 184(9): 5263-5270.

[20]

Tsai A, Irrinki A, Kaur J, et al. Toll-like receptor 7 agonist GS-9620 induces HIV expression and HIV-specific immunity in cells from HIV-infected individuals on suppressive antiretroviral therapy. J Virol. 2017; 91(8): e02166-e02216.

[21]

Chuang S-Y, Lin C-H, Sung CT, Fang J-Y. Murine models of psoriasis and their usefulness for drug discovery. Expert Opin Drug Discov. 2018; 13(6): 551-562.

[22]

Ortiz-Lopez LI, Choudhary V, Bollag WB. Updated perspectives on keratinocytes and psoriasis: keratinocytes are more than innocent bystanders. Psoriasis Auckl NZ. 2022; 12: 73-87.

[23]

Lowes MA, Suárez-Fariñas M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol. 2014; 32: 227-255.

[24]

Nograles KE, Zaba LC, Guttman-Yassky E, et al. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol. 2008; 159(5): 1092-1102.

[25]

Casciaro M, Di Salvo E, Gangemi S. HMGB-1 in psoriasis. Biomolecules. 2021; 12(1):60.

[26]

Sukseree S, Eckhart L, Tschachler E, Watanapokasin R. Autophagy in epithelial homeostasis and defense. Front Biosci (Elite Ed). 2013; 5(3): 1000-1010.

[27]

Mizushima N, Kuma A, Kobayashi Y, et al. Mouse Apg16L, a novel WD-repeat protein, targets to the autophagic isolation membrane with the Apg12-Apg5 conjugate. J Cell Sci. 2003; 116(Pt 9): 1679-1688.

[28]

Virgin HW, Levine B. Autophagy genes in immunity. Nat Immunol. 2009; 10(5): 461-470.

[29]

Saitoh T, Fujita N, Jang MH, et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature. 2008; 456(7219): 264-268.

[30]

Sutterwala FS, Ogura Y, Szczepanik M, et al. Critical role for NALP3/CIAS1/cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity. 2006; 24(3): 317-327.

Rights & permissions

2026 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.

PDF (3848KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉